Trials / Terminated
TerminatedNCT00833430
Avascular Necrosis (AVN) Long-Term Follow-up
Hedrocel Avascular Necrosis (AVN) Intervention Implant
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
Long-term follow-up of IDE patients for publication
Detailed description
This device (Hedrocel AVN Intervention Implant) was approved via 510(k) on April 15, 2005. One site was left open to follow patients to 5 year follow-up for publication of device survivorship.
Conditions
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2013-02-01
- Completion
- 2013-02-01
- First posted
- 2009-02-02
- Last updated
- 2016-02-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00833430. Inclusion in this directory is not an endorsement.